6 research outputs found
Lima Bean
No full textAccording to the taxonomy, the bean belongs to the genus Phaseolus, which includes approximately 35 species of which 4 are cultivated: P. vulgaris L.; P. lunatus L.; P. coccineus L., and P. acutifolius L. (Arias-Restrepo et al. 2007). Phaseolus lunatus
L. belongs to the Fabaceae family, and there are two domesticated genetic stocks from two different wild forms with two seed morphologies, small and large (Debouk 2019). The small seeds are known as ib., patashete and futuna (Yucatan, Chiapas, and Jalapa, Mexico, respectively), caballero bean (Cuba), ixtapacal (Guatemala), chilipuca (El Salvador), haba (Puerto Rico and Panama), sieva and comba (Colombia), and guaracaro (Venezuela), among others. The large seeds are known as lima, layo and pallar (Peru), torta (Colombia), palato (Bolivia), and manteotto (Argentina) (Debouk 2019). It is proposed that P. lunatus could have originated in the Neotropical region of America, ranging from Mexico to Chile, passing through the Andean region of
Peru. It is believed that its origin is found in Guatemala since in this area the wild progenitor of this species was found; on the other hand, molecular studies propose that its origin is found in the Andean zone and that its distribution throughout the
Americas was given by domestication (FAO 2018)
Addition of roselle and mango peel powder in tortilla chips: a strategy for increasing their functionality
No full textA snapshot of antimicrobial resistance in Mexico. Results from 47 centers from 20 states during a six-month period.
No full textAIM:We aimed to assess the resistance rates of antimicrobial-resistant, in bacterial pathogens of epidemiological importance in 47 Mexican centers. MATERIAL AND METHODS:In this retrospective study, we included a stratified sample of 47 centers, covering 20 Mexican states. Selected isolates considered as potential causatives of disease collected over a 6-month period were included. Laboratories employed their usual methods to perform microbiological studies. The results were deposited into a database and analyzed with the WHONET 5.6 software. RESULTS:In this 6-month study, a total of 22,943 strains were included. Regarding Gram-negatives, carbapenem resistance was detected in ≤ 3% in Escherichia coli, 12.5% in Klebsiella sp. and Enterobacter sp., and up to 40% in Pseudomonas aeruginosa; in the latter, the resistance rate for piperacillin-tazobactam (TZP) was as high as 19.1%. In Acinetobacter sp., resistance rates for cefepime, ciprofloxacin, meropenem, and TZP were higher than 50%. Regarding Gram-positives, methicillin resistance in Staphylococcus aureus (MRSA) was as high as 21.4%, and vancomycin (VAN) resistance reached up to 21% in Enterococcus faecium. Acinetobacter sp. presented the highest multidrug resistance (53%) followed by Klebsiella sp. (22.6%) and E. coli (19.4%). CONCLUSION:The multidrug resistance of Acinetobacter sp., Klebsiella sp. and E. coli and the carbapenem resistance in specific groups of enterobacteria deserve special attention in Mexico. Vancomycin-resistant enterococci (VRE) and MRSA are common in our hospitals. Our results present valuable information for the implementation of measures to control drug resistance
